Not investment advice. Educational platform. See Disclaimer.
NYSE: CVS
CVS Health Corporation
Healthcare | Medical - Healthcare Plans
$97.23as of 2026-09-03 12:08 UTC
Market Cap$123.6B
Volume5.40M
EPS (TTM)$1.39
CVS Health Corporation (NYSE: CVS) is a $123.6B medical - healthcare plans company trading at $97.23 — 70.0× trailing earnings, yielding 2.75%. Figures from SEC EDGAR and market feeds; updated 2026-09-03 12:08 UTC.
52-Week Range
Low $77.61High $110.68
What CVS Health Corporation does
The company operates through four reportable segments: Health Care Benefits, Health Services, Pharmacy Consumer Wellness, and Corporate/Other. The Chief Executive Officer evaluates segment performance primarily using adjusted operating income, which excludes items like amortization of intangible assets and net realized capital gains or losses that fall outside the ordinary course of business.
Summarized from CVS Health Corporation’s SEC filings · Read the filing ↗
2026-03-19Exec ChangeDeparture of directors or certain officers; election of directors; appointment of certain officers; compensatory arrangements of certain officersEstimatedSEC 8-K →
The company operates through four reportable segments: Health Care Benefits, Health Services, Pharmacy Consumer Wellness, and Corporate/Other.
What is CVS's valuation?
CVS trades at $97.23, 69.95× trailing earnings, 12.40× EV/EBITDA, as of 2026-09-03. It carries a 2.75% dividend yield.
When did CVS last file with the SEC?
CVS Health Corporation's most recent SEC filing on record is a 8-K filed 2026-05-18. All filings link to their SEC EDGAR originals above.
Where does this data come from?
SEC EDGAR filings and public market data feeds, fetched 2026-09-03 12:08 UTC. This page is also available as JSON at /api/data?ticker=CVS and is emitted with FAQPage structured data for machine reading.
For you
Charts, 10-year financials, peer comparison, screening and portfolio tracking for CVS and 5,000+ tickers.
